Development of experimental autoimmune encephalomyelitis critically depends on CD137 ligand signaling

Journal of Neuroscience

Volumn 32, Issue 50, 2012, Pages 18246-18252

  Martínez Gómez, Julia M ^a,b   Ludovic Croxford, J ^a,b   Yeo, Kim Pin ^a,b   Angeli, Véronique ^a,b   Schwarz, Herbert ^a,b,c   Gasser, Stephan ^a,b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CD137 LIGAND; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DEMYELINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE MICROSCOPY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LYMPH NODE CELL; MALE; MONONUCLEAR CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH1 CELL; TH17 CELL;

ANIMALS; ANTIGENS, CD137; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; SIGNAL TRANSDUCTION;

EID: 84870997325     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2473-12.2012     Document Type: Article

References (30)

1. Bailey SL, Schreiner B, McMahon EJ, Miller SD (2007) CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. Nat Immunol 8:172-180. CrossRef Medline
2. Baxter AG (2007) The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol 7:904-912. CrossRef Medline
3. Chang TT, Jabs C, Sobel RA, Kuchroo VK, Sharpe AH (1999) Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. J Exp Med 190:733-740. CrossRef Medline
4. Croxford JL, O'Neill JK, Ali RR, Browne K, Byrnes AP, Dallman MJ, Wood MJ, Feldmann M, Baker D (1998a) Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis. Eur J Immunol 28:3904-3916. CrossRef Medline
5. Croxford JL, Triantaphyllopoulos K, Podhajcer OL, Feldmann M, Baker D, Chernajovsky Y (1998b) Cytokine gene therapy in experimental allergic encephalomyelitis by injection of plasmid DNA-cationic liposome complex into the central nervous system. J Immunol 160:5181-5187. Medline
6. Cruz-Orengo L, Holman DW, Dorsey D, Zhou L, Zhang P, Wright M, Mc-Candless EE, Patel JR, Luker GD, Littman DR, Russell JH, Klein RS (2011) CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J Exp Med 208:327-339. CrossRef Medline
7. Drenkard D, Becke FM, Langstein J, Spruss T, Kunz-Schughart LA, Tan TE, Lim YC, Schwarz H (2007) CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity. FASEB J 21:456-463. CrossRef Medline
8. Elpek KG, Yolcu ES, Franke DDH, Lacelle C, Schabowsky RH, Shirwan H (2007) Ex-vivo expansion of CD4(+)CD25(+)FoxP3(+) T regulatory cells based on synergy between IL-2 and 4-1BB signaling. J Immunol 179:7295-7304. Medline
9. Engelhardt B, Ransohoff RM (2005) The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol 26:485-495. CrossRef Medline
10. Gimenez MAT, Sim JE, Russell JH (2004) TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation. J Neuroimmunol 151:116-125. CrossRef Medline
11. Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393-407. CrossRef Medline
12. Jeon HJ, Choi JH, Jung IH, Park JG, Lee MR, Lee MN, Kim B, Yoo JY, Jeong SJ, Kim DY, Park JE, Park HY, Kwack K, Choi BK, Kwon BS, Oh GT (2010) CD137 (4-1BB) Deficiency reduces atherosclerosis in hyperlipidemic mice. Circulation 121:1124-1133. CrossRef Medline
13. Juedes AE, Ruddle NH (2001) Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J Immunol 166:5168-5175. Medline
14. Kim HJ, Lee JS, Kim JD, Cha HJ, Kim A, Lee SK, Lee SC, Kwon BS, Mittler RS, Cho HR, Kwon B (2012) Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cellmediated acute tissue inflammation. Proc Natl Acad Sci U S A 109:E13-E22. CrossRef Medline
15. Kim YH, Choi BK, Shin SM, Kim CH, Oh HS, Park SH, Lee DG, Lee MJ, Kim KH, Vinay DS, Kwon BS (2011) 4-1BB triggering ameliorates experimental autoimmune encephalomyelitis by modulating the balance between Th17 and regulatory T cells. J Immunol 187:1120-1128. CrossRef Medline
16. King IL, Dickendesher TL, Segal BM (2009) Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 113:3190-3197. CrossRef Medline
17. Liu GZ, Gomes AC, Putheti P, Karrenbauer V, Kostulas K, Press R, Hillert J, Hjelmström P, Gao XG (2006) Increased soluble 4-1BB ligand (4-1BBL) levels in peripheral blood of patients with multiple sclerosis. Scand J Immunol 64:412-419. CrossRef Medline
18. high regulatory T cells in peripheral blood of patients with multiple sclerosis. Clin Exp Immunol 154:22-29. CrossRef Medline
19. McColl SR, Staykova MA, Wozniak A, Fordham S, Bruce J, Willenborg DO (1998) Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. J Immunol 161: 6421-6426. Medline
20. hi monocytes are crucial for the effector phase of autoimmunity in the central nervous system. Brain 132: 2487-2500. CrossRef Medline
21. Murphy ÁC, Lalor SJ, Lynch MA, Mills KHG (2010) Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun 24: 641-651. CrossRef Medline
22. Palazón A, Teijeira A, Martínez-Forero I, Hervás-Stubbs S, Roncal C, Peñuelas I, Dubrot J, Morales-Kastresana A, Pérez-Gracia JL, Ochoa MC, Ochoa-Callejero L, Martínez A, Luque A, Dinchuk J, Rouzaut A, Jure-Kunkel M, Melero I (2011) Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes. Cancer Res 71:801-811. CrossRef Medline
23. Racke MK, Ratts RB, Arredondo L, Perrin PJ, Lovett-Racke A (2000) The role of costimulation in autoimmune demyelination. J Neuroimmunol 107:205-215. CrossRef Medline
24. Shao Z, Schwarz H (2011) CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction. J Leukoc Biol 89:21-29. CrossRef Medline
25. Sharief MK (2002) Heightened intrathecal release of soluble CD137 in patients with multiple sclerosis. Eur J Neurol 9:49-54. CrossRef Medline
26. Sun Y, Lin X, Chen HM, Wu Q, Subudhi SK, Chen L, Fu YX (2002) Administration of agonistic anti-4-1BB monoclonal antibody leads to the amelioration of experimental autoimmune encephalomyelitis. J Immunol 168:1457-1465. Medline
27. Wang C, Lin GHY, McPherson AJ, Watts TH (2009) Immune regulation by 4-1BB and 4-1BBL: complexities and challenges. Immunol Rev 229:192-215. CrossRef Medline
28. Yeo AY, Martínez Gómez JM, Croxford JL, Gasser S, Ling EA, Schwarz H (2011) CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species. J Neuroinflamm 9:173.
29. Zhang H, Podojil JR, Chang J, Luo X, Miller SD (2010) TGF-β-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis. J Immunol 184:6629-6636. CrossRef Medline
30. Zhang P, Gao F, Wang Q, Wang X, Zhu F, Ma C, Sun W, Zhang L (2007) Agonistic anti-4-1BB antibody promotes the expansion of natural regulatory T cells while maintaining Foxp3 expression. Scand J Immunol 66: 435-440. CrossRef Medline